Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Meglumine antimoniate plus co-trimoxazole versus meglumine antimoniate alone for cutaneous leishmaniasis
TCTR20251014007Phase 1Completed
- Sponsor
- Combined Military Hospital Quetta
- Start
- Mar 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised trial in cutaneous leishmaniasis (CL) comparing Meglumine antimoniate plus co-trimoxazole with Meglumine antimoniate plus placebo (2 arms). Primary endpoint: Clinical cure by week 12. Started Mar 2025; status: completed.
02
Drugs
meglumine antimoniatetrimethoprim + sulfamethoxazole
03
Conditions
cutaneous leishmaniasis (CL)
Beyond the preview
Go deeper on TCTR20251014007.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20251014007.